Irazú Oncology Secures Bridge Funding, Expands Leadership Team and Facilities
March 04, 2025 08:30 ET
|
Irazu Oncology
Dr. Mayukh Das, joined Irazú as CMO, bringing extensive oncology drug development experience from leadership roles at global pharmaceutical companies.
Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
February 26, 2025 07:00 ET
|
Immunocore Holdings plc
KIMMTRAK (tebentafusp) Q4 net sales of $84.1 million and $310.0 million for full year 2024; continued growth expected in 2025 Executing on KIMMTRAK lifecycle management with two Phase 3 trials...
Immunotherapy Drugs Market Research 2024-2030 with Analyst Recommendations - Adoption of AI in Drug Discovery and Combination Therapies
February 26, 2025 06:42 ET
|
Research and Markets
Dublin, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The "Immunotherapy Drugs Market (2025 Edition): Analysis By Indication (Cancer, Autoimmune & Inflammatory Diseases, Other Indications), By Drug Type, By...
Medicenna Reports MDNA11’s Compelling Anti-Cancer Activity is Associated with Significant Expansion of ‘Stem-Like’ Cancer Fighting Immune Cells at the Inaugural AACR-Immuno-Oncology Conference and Provides ABILITY-1 Study Update
February 25, 2025 07:00 ET
|
Medicenna Therapeutics Corp.
MDNA11 significantly expands a unique population of ‘stem-like’ CD8+ T cells that leads to more persistent and effective anti-tumor activity MDNA11 has shown durable single agent activity, with a...
Pancreatic Cancer Treatment Market to Surge to USD 10.2 Billion by 2034, Driven by Advancements in Immunotherapies and Early Diagnostics – Transparency Market Research
February 06, 2025 11:00 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. - , Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Pancreatic Cancer Treatment Market is set for remarkable growth, projected to reach...
CytoMed Therapeutics announces Chairman’s Letter to the Company’s shareholders
February 06, 2025 07:20 ET
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”) today released a letter to shareholders from the Chairman of the Company’s Board...
Medicenna Therapeutics to Participate in Two Healthcare Investor Conferences in February 2025
February 05, 2025 07:00 ET
|
Medicenna Therapeutics Corp.
TORONTO and HOUSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused...
Non-Muscle Invasive Bladder Cancer Market Poised for $21.1 Bn Surge by 2034, Driven by Expanding Therapeutic Innovations | Transparency Market Research
January 31, 2025 09:45 ET
|
Transparency Market Research
Wilmington, Delaware, Transparency Market Research Inc. –, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The global non-muscle invasive bladder cancer (NMIBC) market (非筋肉浸潤性膀胱癌市場), valued at US$ 2.6 billion in...
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5
January 29, 2025 08:00 ET
|
Calidi Biotherapeutics, Inc
SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor...
Cancer Immunotherapy Market, Valued at $125.68 Billion in 2025, Sees $194.64 Billion Opportunity by 2029 - Dominated by Amgen, AstraZeneca, Roche, Bayer, and Eli Lilly
January 28, 2025 11:29 ET
|
Research and Markets
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market Report 2025" has been added to ResearchAndMarkets.com's offering.This Cancer Immunotherapy market report covers market...